Navigation Links
Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
Date:2/5/2009

n thousands, except share and per share amounts) Stock GAAP as Non-GAAP Compensation Reported Income Statement Classifications: Revenue $14,967 $14,967 Research and development (35,272) $(2,492) (37,764) General and administrative (15,711) (3,955) (19,666) Depreciation and amortization (1,493) (1,493) Interest income 4,819 4,819 Interest expense (218) (218) Summary: Net loss: $(32,908) $(6,447) $(39,355) Net loss per share - basic and diluted: $(1.46) $(0.29) $(1.75) Weighted average number of shares outstanding: 22,493,803 22,493,803 Table 5 Amicus Therapeutics, Inc. Reconciliation of GAAP to non-GAAP Measures for the Statement of Operations Information for Year Ended December 31, 2007 (Unaudited) (In thousands, except share and per share amounts) Change in Fair Value of Preferred Warrant Stock Stock GAAP as Non-GAAP Liability Accretion Compensation Reported Income Statement Classifications: Revenue $1,784 $1,784 Research and development (29,480) $- $- $(1,594) (31,074) General and administrative (12,887) (2,391) (15,278) Depreciat
'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
2. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
3. Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference
4. Amicus Therapeutics Announces Third Quarter 2008 Financial Results
5. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
6. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
7. Amicus Therapeutics Opens Research Facility in San Diego
8. Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
9. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
10. Amicus Therapeutics Announces First Quarter 2008 Financial Results
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 AACC ... to the 2015 AACC Annual Meeting & Clinical ... from July 26–30. The meeting showcased revolutionary advancements ... the ability of healthcare providers to diagnose patients ... effective medical treatment. As of ...
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
(Date:7/30/2015)... across the globe, ISN improves the efficiency and effectiveness of contractor management systems. ISN,s ... reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... Headquartered in Dallas, TX , ISN has additional offices in Calgary ...
(Date:7/30/2015)... NY (PRWEB) , ... July 30, 2015 , ... As part of its 2015 growth ... material and technical service business units, Whitehouse Laboratories is pleased to announce ... be adjacent to the Container Center of Excellence and will be strictly dedicated to basic ...
Breaking Biology Technology:Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2
... WYE ),announced that, at a meeting today, its Board ... share repurchase program,that authorizes the Company to buy back ... is inclusive of approximately $1.2 billion in,repurchases already executed ... may be suspended for periods or discontinued at any ...
... ZMH ; SWX: ZMH) today announced that it ... an ongoing federal investigation into its,financial relationships with consulting ... into a Deferred Prosecution,Agreement, will pay a civil settlement ... by a federal monitor appointed by the U.S. Department,of ...
... are fruits of strategic plan, WATERTOWN, Mass., ... and discovery, Boston Biomedical Research Institute, an independent,not-for- ... has,recruited seven new scientists, a 23% increase in ... scientists are the fruits of a three-year,strategic planning ...
Cached Biology Technology:Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend 2Zimmer Announces Settlement of Federal Investigation 2Zimmer Announces Settlement of Federal Investigation 3Zimmer Announces Settlement of Federal Investigation 4New Scientists Boost Disease-based Research at Boston Biomedical Research Institute 2New Scientists Boost Disease-based Research at Boston Biomedical Research Institute 3
(Date:7/31/2015)... de julho de 2015 A 10 a. ... será realizada pela BGI de 22-25 de outubro de 2015, ... A conferência está celebrando seu 10 o. aniversário ... se tornou uma das reuniões mais influentes do mundo ... mais dinâmicos, entusiastas e prazerosos. A ...
(Date:7/31/2015)... OXFORD, Conn. , Jul. 31, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... announces that it has filed provisional patent 62/198989 for ... This invention highlights a method to advance crypto-currencies ... technology by introducing a common, uniform way to manage ...
(Date:7/27/2015)...   Zynx Health ™, the market leader ... today announced that its ZynxCarebook ™ mobile ... smartphones and tablets. With this expansion, care team ... ZynxCarebook to securely exchange messages and share assessments ... to other care settings, and improve clinical outcomes ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3
... study in Botswana, Harvard School of Public Health researchers ... resource-poor settings, who receive antiretroviral (ARV) therapy, can achieve ... fully supported health care delivery system and infrastructure help ... 2005 issue of the Journal of Acquired Immune Deficiency ...
... of researchers led by scientists at Memorial Sloan-Kettering Cancer Center ... in early stage clinical trials -- work best in patients ... that plays a central role in the growth and survival ... patients with melanoma and in a minority of patients with ...
... to research reported this week in Current Biology, tsunami ... the 2004 Sumatra-Andaman earthquake was occasionally spectacular, but surprisingly ... misuse in the region. , Less than 100 ... team of ecologists from James Cook University, the Wildlife ...
Cached Biology News:New Therapeutic Target Identified In Inherited Brain Tumor Disorder 2Mutations in the BRAF gene predict sensitivity to a novel class of cancer drugs 2
Request Info...
RABBIT ANTI PORCINE CARBOXYPEPTIDASE B...
albumin from bovine serum (BSA), Texas Red® conjugate...
Mycoplasma Removal Agent (MRA) has been developed for cell culture, to combat the widespread problems caused by contamination of cell cultures with mycoplasma....
Biology Products: